In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Clinical chemistry analyzers are used to perform tests on blood, serum, plasma or urine samples, in order to determine the concentration of analytes such as cholesterol, electrolytes, glucose etc. GlobalData uses proprietary data and analytics to provide a comprehensive report on the clinical chemistry analyzers devices market, including market shares of different players within China. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the clinical chemistry analyzers market in China was F. Hoffmann-La Roche followed by Siemens, Abbott Laboratories, Danaher, Shenzhen Mindray Bio-Medical Electronics, Horiba, Quidelortho, ELITechGroup, EKF Diagnostics, Randox Laboratories and Abaxis.
The Clinical chemistry analyzers market includes the sub-segments Semi-Automated Clinical Chemistry Analyzers, Automated Clinical Chemistry Analyzers.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the clinical chemistry analyzers devices market within China was expected to be over $100m in 2022.
For the latest complete market share analysis of clinical chemistry analyzers device market in China, buy the report here.